Cyclooxygenase 2 augments osteoblastic but suppresses chondrocytic differentiation of CD90+ skeletal stem cells in fracture sites by Samiksha Wasnik, Ram.

Slides:

Advertisements

Similar presentations

Silencing miR-106b accelerates osteogenesis of mesenchymal stem cells and rescues against glucocorticoid-induced osteoporosis by targeting BMP2 Ke Liu,

Advertisements

Volume 24, Issue 2, Pages (February 2016)

Fig. 5 Correlation of RNA expression and protein abundance.

Fig. 4 3D reconfiguration of liquid metals for electronics.

Fig. 2 CFD results. CFD results. Results of CFD simulations in horizontal (left column) and vertical (right column) cross-sections. All models oriented.

Fig. 6 CCR7 neutralizing antibody inhibited CCR7+cell expansion in the kidney, RDLN, and spleen and attenuated renal inflammation and fibrosis. CCR7 neutralizing.

Fig. 1 Map of water stress and shale plays.

Molecular Therapy - Nucleic Acids

Fig. 5 MTAP status remains nonpredictive of responsiveness to nutrient restriction in a panel of tissue-matched cell lines. MTAP status remains nonpredictive.

Fig. 1 Examples of experimental stimuli and behavioral performance.

Fig. 4 Complete separation of water and solute after stable and efficient solar evaporation. Complete separation of water and solute after stable and efficient.

HT synthesis of boronic acids using the building block approach

Single-base validation using ligation-amplification method and qPCR

Fig. 2 IT1t prevents TLR7-mediated inflammation in pDCs.

Fig. 4 CEBPA-p30 mediated activation of Nt5e expression.

Fig. 2 Stratigraphic profile of the Area 15 excavation block showing the diagnostic cultural materials and components alongside the stratigraphic sequence.

Fig. 1 Product lifetime distributions for the eight industrial use sectors plotted as log-normal probability distribution functions (PDF). Product lifetime.

Fig. 5 GP38 localization to the viral envelope and plasma membrane.

Fig. 1 Neu1−/− fibroblasts have characteristics of myofibroblasts.

Fig. 5 EGLN2-mediated HIF1A down-regulation promotes ferroptosis.

Fig. 6 SNP rs is a functional SNP in 22Rv1 cells.

Fig. 5 Blocking of WNT/β-catenin signaling pathway completely abolished COX-2 overexpression–mediated augmentation of CD90+ mSSC osteoblast differentiation.

Fig. 3 The rs risk enhancer is a hub for intrachromosomal and interchromosomal interactions. The rs risk enhancer is a hub for intrachromosomal.

Fig. 1 Distribution of total and fake news shares.

Fig. 1 Local COX-2 overexpression selectively increased the abundance and prolonged the presence of CD90+ mSSCs in the fractured bones. Local COX-2 overexpression.

Fig. 4 Reconstitution of MCs in KitW-sh/W-sh mice increases IL-10+ Breg cells and suppresses the CHS response. Reconstitution of MCs in KitW-sh/W-sh mice.

Fig. 6 RUNX/CBFB interaction inhibitor, Ro5-3335, significantly decreases mouse neurofibroma growth in vivo. RUNX/CBFB interaction inhibitor, Ro5-3335,

Volume 8, Issue 6, Pages (June 2017)

Fig. 5 Analysis of VLPs formed from deletion CP mutants.

Fig. 6 Local COX-2 overexpression targeted CD90+ mSSCs to accelerate bone repair. Local COX-2 overexpression targeted CD90+ mSSCs to accelerate bone repair.

Fig. 2 ODN enhances EV transfer between cells expressing TLR9.

Fig. 2 Hydrogel stress relaxation regulates cell cycle progression from the G1 phase to the S phase. Hydrogel stress relaxation regulates cell cycle progression.

Fig. 2 EUV TG signal. EUV TG signal. Black lines in (A), (B), and (C) are the EUV TG signals from Si3N4 membranes at LTG = 110, 85, and 28 nm, respectively,

Fig. 4 Activation of mitochondrial apoptosis pathway by n-HA.

Fig. 1 A time-course RNA-seq analysis reveals prominent IRF8 expression in the spinal cord during the recovery phase after SCI. A time-course RNA-seq analysis.

Fig. 2 Phenotypic analyses of Bcl11b-deficient Treg cells.

Fig. 1 Histograms of the number of first messages received by men and women in each of our four cities. Histograms of the number of first messages received.

Fig. 3 Transcriptional changes in dKO mice.

Fig. 5 Adenosine A2BR agonist BAY attenuates bone loss in OVX animals.

Fig. 5 Topology structure and strategy for the bottom-up synthesis of structurally uniform carboncones[1,m]. Topology structure and strategy for the bottom-up.

Fig. 2 Regulation of CD73 and CD39 cell membrane expressions and extracellular adenosine levels by ERs in osteoprogenitor cells. Regulation of CD73 and.

Fig. 3 Regulation of CD73 and CD39 cell membrane expression and extracellular adenosine levels by ERs in osteoclasts. Regulation of CD73 and CD39 cell.

Fig. 2 The sex-linked mbt proteome.

Contrast agent uptake for the four different groups of MMA mice

Fig. 2 IRF8 is expressed in CD68+ macrophages after SCI.

Fig. 4 Alternate-day ocular dosing with DECON curbs HSV-1 in a murine model of ocular infection. Alternate-day ocular dosing with DECON curbs HSV-1 in.

Fig. 2 Viperin promotes methionine oxidation of KSHV helicase.

Fig. 4 Adenosine A2BR signaling promote osteogenic and inhibit osteoclast differentiation in vitro. Adenosine A2BR signaling promote osteogenic and inhibit.

Fig. 6 PPAR-γ is a direct target of Suv420h.

Chronic Treg reduction results in dermal fibrosis.

Tregs preferentially regulate TH2 cytokines in skin.

Fig. 5 Skull 1: Tentative reconstruction.

Fig. 4 BS-SEM images, ternary diagrams, and phase maps for the text and reverse sides of the TS. BS-SEM images, ternary diagrams, and phase maps for the.

Fig. 1 Location of the Jirzankal Cemetery.

Fig. 6 MSC encapsulation in vitro within PdBT cross-linked gels.

Fig. 2 Nanofibers inhibit CA IX–associated cancer cell behaviors.

AV3 potentiates the effect of gemcitabine in the PDX model in mice

Fig. 2 The increase in CD90+ mSSC abundance in fractured bones following local COX-2 overexpression depended on MCP-1. The increase in CD90+ mSSC abundance.

Fig. 5 Comparison between the results generated with the proposed new algorithm and the preceding state-of-the-art results for a detail of the Adam panel.

Fig. 5 IL-5–mediated signaling is critical for the development of CD1dintCD5+ Breg precursor cells and IL-10+ Breg cells. IL-5–mediated signaling is critical.

Fig. 5 Effector function of MIH5 isotype variants.

Fig. 5 Density plots showing the relationship between growth responses to extreme events and site-level mean precipitation from all sites (N = 1314). Density.

Fig. 5 The complex of antibody and dye can afford to target imaging in the NIR-II window. The complex of antibody and dye can afford to target imaging.

Fig. 4 Behavior of resistance peak near density nm = 5.

Fig. 2 Comparison between the different reflective metasurface proposals when θi = 0° and θr = 70°. Comparison between the different reflective metasurface.

Fig. 1 Overview of amber clast with synchrotron x-ray μCT image of articulated snake skeleton (DIP-S-0907). Overview of amber clast with synchrotron x-ray.

Fig. 3 MCA-mediated neutrophil recruitment accelerates bacterial clearance in the skin. MCA-mediated neutrophil recruitment accelerates bacterial clearance.

Fig. 3 Gene expression analysis in 48-plex drug treatment experiments.

Fig. 3 Evaluation of PTMAO immunogenicity.

Cxxc1-deficient TH17 cells exhibit a Treg cell–like expression profile

Presentation transcript:

Cyclooxygenase 2 augments osteoblastic but suppresses chondrocytic differentiation of CD90+ skeletal stem cells in fracture sites by Samiksha Wasnik, Ram Lakhan, David J. Baylink, Charles H. Rundle, Yi Xu, Jintao Zhang, Xuezhong Qin, Kin-Hing William Lau, Edmundo E. Carreon, and Xiaolei Tang Science Volume 5(7):eaaw2108 July 31, 2019 Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).

Fig. 1 Local COX-2 overexpression selectively increased the abundance and prolonged the presence of CD90+ mSSCs in the fractured bones. Local COX-2 overexpression selectively increased the abundance and prolonged the presence of CD90+ mSSCs in the fractured bones. (A) B6 mice were subjected to femur fracture surgery (Fx). On the following day, animals received in fracture sites one of the following treatments (Tx): no treatment (No), a control AAV vector (Ctr), or the AAV.COX-2 vector (COX-2). On days 3, 4, 7 and 10 following the treatments, the fractured bones and contralateral intact bones were harvested and the MNCs were isolated as described in Materials and Methods. The isolated MNCs were analyzed by FACS. (B) Gating strategy. SSC, side scatter; FSC, forward scatter. (C) Representative FACS plots show the expressions of AlphaV (top), AlphaV and CD90 (middle), and AlphaV and 6C3 (bottom) among CD45−Tie2− cells. (D) Cumulative data show the frequencies of CD90+ mSSCs on day 7 following the treatments. (E) Representative FACS plots show the expressions of CD90 and 6C3 among mSSCs. (F) Representative FACS plots show the expressions of AlphaV and CD90 among CD45−Tie2− cells on days 3, 4, and 10 following the treatments. Where applicable, data are means ± SEM. **P < 0.01, ***P < 0.001, ****P < 0.0001, #not significant; n = 3 to 5. Samiksha Wasnik et al. Sci Adv 2019;5:eaaw2108 Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).

Fig. 2 The increase in CD90+ mSSC abundance in fractured bones following local COX-2 overexpression depended on MCP-1. The increase in CD90+ mSSC abundance in fractured bones following local COX-2 overexpression depended on MCP-1. (A) B6 mice received femur fracture surgery and treatments as described in Fig. 1. On day 4 following the treatments, the fractured bones and contralateral intact bones were harvested and analyzed by RT-qPCR. Data are shown in (B). (B) Data show the expression of MCP-1 mRNA. GAPDH, glyceraldehyde-3-phosphate dehydrogenase. (C) B6 mice received femur fracture surgery. Beginning on the day of fracture surgery, the mice subcutaneously received a daily dose of either PBS or the neutralizing anti–MCP-1 mAb (anti–MCP-1, clone 2H5) near the fracture sites for three consecutive days (±mAb). In addition, on the day following the fracture surgery, half of the animals from each group received a treatment of a control AAV vector and the other half the AAV.COX-2 vector in fracture sites. On day 4 following the treatments, the fractured bones and contralateral intact bones were harvested and the MNCs were isolated for analyses by FACS. Data are shown in (D) and (E). (D) Representative FACS plots show the expression of CD90 among mSSCs. (E) Cumulative data show the frequencies of CD90+ mSSCs in the fractured bones. Where applicable, data are means ± SEM. **P < 0.01, ***P < 0.001, ****P < 0.0001; n = 3 to 5. Samiksha Wasnik et al. Sci Adv 2019;5:eaaw2108 Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).

Fig. 3 CD90+ mSSCs isolated from COX-2–overexpressed fractured bones, when compared to controls, displayed significantly augmented and accelerated osteoblast differentiation in vitro. CD90+ mSSCs isolated from COX-2–overexpressed fractured bones, when compared to controls, displayed significantly augmented and accelerated osteoblast differentiation in vitro. (A) B6 mice received femur fracture surgery and treatments as described in Fig. 1. On day 4 following the treatments, the fractured bones were harvested and the CD90+ mSSCs were purified as described in Materials and Methods. The purified CD90+ mSSCs were analyzed by RT-qPCR. Data are shown in (B). (B) Data show the mRNA expressions of the following genes: Runx2, OCN, OSX, BMP2, and ALP. (C) The purified CD90+ mSSCs in (A) were analyzed by FACS. Data show the frequencies of OSX+ and Runx2+ cells among the CD90+ mSSCs (left), as well as the MFIs of the expressions of OSX and Runx2 (right). (D) The purified CD90+ mSSCs in (A) were directly cultured in an osteoblast differentiation medium for 21 days. Data are representative images of the cultured cells stained with Alizarin Red. (E) The purified CD90+ mSSCs in (A) were first expanded in an MSC medium for 1 week and then cultured in the osteoblast differentiation medium for 21 days. Data are representative images of the cultured cells stained with Alizarin Red. (F) The purified CD90+ mSSCs in (A) were cultured in the osteoblast differentiation medium. On weeks 1, 2, and 3, the cultured cells were stained with Alizarin Red. Data show representative images of the cultured cells stained with Alizarin Red. (G) Data show the absorbance at 405 nm of solubilized Alizarin Red–stained cells in (F). Where applicable, data are means ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001; n = 3 to 5. Photo credit: Samiksha Wasnik, Loma Linda University. Samiksha Wasnik et al. Sci Adv 2019;5:eaaw2108 Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).

Fig. 4 CD90+ mSSCs isolated from COX-2–overexpressed fractured bones, when compared to control-treated fractured bones, displayed significantly reduced chondrogenic differentiation in vitro. CD90+ mSSCs isolated from COX-2–overexpressed fractured bones, when compared to control-treated fractured bones, displayed significantly reduced chondrogenic differentiation in vitro. (A) B6 mice were subjected to femur fracture surgery and, on the following day, received one of the following treatments in the fracture sites: a control vector and the AAV.COX-2 vector. Four days later, the fractured bones were harvested and CD90+ mSSCs and CD90− mesenchymal cells were purified for analyses by RT-qPCR and an in vitro chondrogenesis assay. Data are shown in (B) and (C). (B) The mRNA expressions of Sox9, Nkx3.2, and Col2a1 in the cells purified in (A) are shown. (C) A total of 5.0 × 104 CD90+ mSSCs purified in (A) were seeded in 24-well tissue culture plates for a chondrogenic micromass culture for 21 days as described in Materials and Methods. Representative images of Alcian blue staining are shown. (D) B6 mice were subjected to femur fracture surgery and received vector treatments as described in (A). Four days later, the fractured bones were harvested and the MNCs were purified for analyses by FACS. Data are shown in (E) and (F). (E) Representative FACS histograms show CD200+ cells among CD90+ mSSCs. (F) Cumulative data of (E) show the percentage of CD200+ cells among CD90+ mSSCs (left) and the percentage of CD200− cells among CD90+ mSSCs (right). Where applicable, data are means ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001; n = 3 to 5. Samiksha Wasnik et al. Sci Adv 2019;5:eaaw2108 Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).

Fig. 5 Blocking of WNT/β-catenin signaling pathway completely abolished COX-2 overexpression–mediated augmentation of CD90+ mSSC osteoblast differentiation potential in fractured bones. Blocking of WNT/β-catenin signaling pathway completely abolished COX-2 overexpression–mediated augmentation of CD90+ mSSC osteoblast differentiation potential in fractured bones. (A) B6 mice were subjected to femur fracture surgery and, on the second day, received one of the following treatments in the fracture sites: a control AAV vector and the AAV.COX-2 vector. Four days after the fracture surgery, the fractured bones were collected and the CD90+ mSSCs were purified as described in Materials and Methods. The purified CD90+ mSSCs were analyzed by RT-qPCR. Data are shown in (B). (B) mRNA expressions of WNT ligands (WNT3a and WNT7a; top), WNT signaling molecules (β-catenin, TCF-1, and TCF-3; middle), and negative regulators of WNT signaling (Axin-2 and SOST; bottom). (C) B6 mice were subjected to femur fracture surgery and, beginning on the same day, subcutaneously received a daily dose of either vehicle (VC) or ICG001 (an inhibitor for WNT/β-catenin/TCF-mediated transcription) near fracture sites until bones were harvested. On the second day following the fracture surgery, half of the animals in each group received a control AAV vector and the other half received the AAV.COX-2 vector in the fracture sites. Four days after the fracture surgery, the fractured bones were harvested and the CD90+ mSSCs were purified. The purified CD90+ mSSCs were analyzed by RT-qPCR and an in vitro nodule assay. Data are shown in (D) to (F). (D) Data show the mRNA expression of β-catenin. (E) Data show mRNA expressions of the genes necessary for bone formation, i.e., Runx2, OSX, and OCN. (F) Data show representative images of CD90+ mSSCs that were cultured in the osteoblast differentiation medium for 14 and 21 days and stained with Alizarin Red. Where applicable, data are means ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001; n = 3 to 5. Photo credit: Samiksha Wasnik, Loma Linda University. Samiksha Wasnik et al. Sci Adv 2019;5:eaaw2108 Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).

Fig. 6 Local COX-2 overexpression targeted CD90+ mSSCs to accelerate bone repair. Local COX-2 overexpression targeted CD90+ mSSCs to accelerate bone repair. (A) B6 mice were subjected to tibial fracture surgery. Immediately after the fracture surgery and on the following two consecutive days, the animals subcutaneously received a daily dose of either PBS or the depleting anti-CD90 mAb (clone 30H12) near fracture sites (±mAb). The Ab doses were 200, 100, and 100 μg on days 0, 1, and 2, respectively. Ten days after the fracture surgery, the fractured bones were harvested and the MNCs were isolated for analysis of the expressions of CD90 and CD11b by FACS. Data are shown in (B). (B) Representative FACS plots show the frequencies of CD90+ and CD11b+ cells. (C) B6 mice were subjected to tibial fracture surgery and received either PBS or the clone 30H12 (mAb) as described in (A). In addition, on the second day following the fracture surgery, half of the animals that were administered with PBS or the clone 30H12 received no treatment and the other half received the AAV.COX-2 vector in the fracture sites. In addition, a group of animals that received only a control AAV vector in fracture sites was also included as a control. On days 4, 10, and 21, the fractured bones were examined by x-ray. On day 21, the fractured bones were harvested and analyzed by micro-computed tomography (μCT). Data are shown in (D) to (G). (D) Representative x-ray images on day 21 are shown (the contours indicate callus sizes). (E) The callus sizes were quantified by an imaging software. Data show the cumulative callus areas of five mice in each group. (F) The following parameters of new bone formation from the μCT analysis are shown: connectivity density (Conn. density), bone volume/volume of interest (BV/TV), bone mineral density (BMD), trabecular number (DT-Tb.N), trabecular thickness (DT-Tb.Th), and trabecular space (DT-Tb.sp). (G) Representative reconstructed three-dimensional images are shown. Where applicable, data are means ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001; n = 3 to 5. Samiksha Wasnik et al. Sci Adv 2019;5:eaaw2108 Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).